1.60
-0.15(-8.57%)
Currency In USD
| Previous Close | 1.75 |
| Open | 1.7 |
| Day High | 1.75 |
| Day Low | 1.49 |
| 52-Week High | 2.8 |
| 52-Week Low | 0.97 |
| Volume | 69,534 |
| Average Volume | 54,167 |
| Market Cap | 60.23M |
| PE | -1.95 |
| EPS | -0.82 |
| Moving Average 50 Days | 1.42 |
| Moving Average 200 Days | 1.39 |
| Change | -0.15 |
If you invested $1000 in Apyx Medical Corporation (APYX) since IPO date, it would be worth $247.3 as of December 27, 2024 at a share price of $1.6. Whereas If you bought $1000 worth of Apyx Medical Corporation (APYX) shares 3 years ago, it would be worth $123.36 as of December 27, 2024 at a share price of $1.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire Inc.
Nov 27, 2024 1:00 PM GMT
CLEARWATER, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
GlobeNewswire Inc.
Nov 12, 2024 9:05 PM GMT
CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, today
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
GlobeNewswire Inc.
Nov 08, 2024 12:05 PM GMT
CLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion®, tod